Clinical trial
The IN.PACT Global Clinical Study for the Treatment of Comprehensive Superficial Femoral and/or Popliteal Artery Lesions Using the IN.PACT Admiral™ Drug-Eluting Balloon.
NCT01609296 is registered in ClinicalTrials.gov with Medtronic Endovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The IN.PACT Global Clinical Study for the Treatment of Comprehensive Superficial Femoral and/or Popliteal Artery Lesions Using the IN.PACT Admiral™ Drug-Eluting Balloon.
- Lead sponsor
- Medtronic Endovascular
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2012
- Completion date
- January 17, 2020
- Enrollment
- 1,535 (actual)
- Sites
- 65
Conditions
As the registry lists them; a condition with its own page is linked.